Tailong Pharmaceutical announcement, as of the announcement date, the company's first phase of the employee stock ownership plan held by the company's 5.9719 million shares have been sold. According to the relevant provisions of the employee Stock ownership Plan of Henan Tailong Pharmaceutical Co., Ltd., the first phase of the employee stock ownership plan has been implemented and terminated automatically, and property liquidation and distribution will be carried out in the follow-up.
The chairman of the company is Li Jingliang. Mr. Li Jingliang: born in January 1969 with a master's degree, he once served as the general manager of the company, vice chairman of the company and chairman of Zhongsheng Group. He is currently the chairman of the company.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.